Zhang, Z., Shahinfar, S., Keane, W. F., Ramjit, D., Dickson, T. Z., Gleim, G. W.
, Mogensen, C. E. S., de Zeeuw, D., Brenner, B. M. & Snapinn, S. M. (2005).
Importance of baseline distribution of proteinuria in renal outcomes trials. Lessons from the Reduction of Endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.
Journal of the American Society of Nephrology,
16, 1775-1780.